BioCentury
ARTICLE | Company News

Theratechnologies, AOP Orphan sales and marketing update

September 14, 2015 7:00 AM UTC

Egrifta tesamorelin to treat lipodystrophy in HIV patients is now available in European countries as part of a named-patient program. The analog of growth hormone-releasing factor is available in th...